Skip to main content
Equibles
ABT logo

ABT · Abbott Laboratories · Investor Relations

Track ABT — free

Use ABT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$108.52 +1.27 (+1.18%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$187.95B
Shares
1.73B
Volume · Nov 13 6.2M Avg daily vol (3M) 8.95M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-10-21 Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
2026-10-21 Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
2026-08-20 Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
2026-07-16 Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
2026-04-16 Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
2026-03-23 Abbott completes acquisition of Exact Sciences
2026-01-22 Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
2025-11-20 Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

Past events

Date Event Type
2026-10-21 Q3 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-07-16 Q2 Earnings conference call (announced in 8-K) Earnings call
2026-04-16 Q1 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-01-22 Q4 Earnings conference call (announced in 8-K) Earnings call
2025-11-20 ABBOTT CONFERENCE CALL Conference
2025-10-15 Q3 2025 ABBOTT EARNINGS CONFERENCE CALL Earnings call
2025-07-17 Q2 2025 ABBOTT EARNINGS CONFERENCE CALL Earnings call
2025-04-16 Q1 2025 ABBOTT EARNINGS CONFERENCE CALL Earnings call
2025-01-22 Q4 2024 ABBOTT EARNINGS CONFERENCE CALL Earnings call
2024-10-16 Q3 2024 ABBOTT EARNINGS CONFERENCE CALL Earnings call

Source: https://www.abbott.com/investors.html

Key facts CIK 1800 CUSIP 002824100 13F (30d) 2389 filings 2259 filers Visit website Investor relations